Could an MS drug 'erase' traumatic memories?

Conclusion Despite what the media has reported, the evidence from this study does not prove that it is possible to "erase" painful memories in humans. All we can safely say is that this study has found that the drug fingolimod can reduce fear-related behaviour in genetically modified mice with defects in their immune system. These mice are known to have impaired acquisition and ability to perform cognitive tasks. Whether fingolimod would have a similar effect on humans who did not have an impaired immune system or cognitive function is unknown. Changes in memory and anxiety levels were not reported in any of the human clinical trials of fingolimod used in the treatment of multiple sclerosis. There were many listed side effects, including headaches affecting 1 in 10 people, and depression affecting between 1 in 10 and 1 in 100 people. This means that the risks of taking fingolimod solely as an anti-anxiety drug may well outweigh any benefits. If you are troubled by traumatic events in your past, ask your GP for advice. Many people with post-traumatic stress disorder respond well to a combination of medication and talking therapies such as cognitive behavioural therapy. Analysis by Bazian. Edited by NHS Choices. Follow Behind the Headlines on Twitter. Join the Healthy Evidence forum. Links To The Headlines Drug could rid people of bad memories and trauma. Mail Online, May 26 2014 Could pill wipe out our bad memories? Drug used to treat multiple sclerosis foun...
Source: NHS News Feed - Category: Consumer Health News Tags: Mental health Neurology Medication Source Type: news